Sign in

Vass Vassiliou

@vassv.bsky.social
321 followers 149 following 46 posts

Professor of Cardiology loving imaging, valves and prevention- not necessarily in this order! EAPC Exec Board, SCMR comms chair- DIY enthusiast yes, completer not really

PostsRepliesMedia
Reposted by Vass Vassiliou
European Society of Cardiology @escardio.bsky.social · 09/01/2026
💚 Join us from 23-25 April in Ljubljana, Slovenia, for #ESCPrev26! Experience cutting-edge science, practical insights and real connections with your community. Register now to benefit from early fees 👉 bit.ly/49tJh0Y #EAPC_ESC #prevention
074
Vass Vassiliou @vassv.bsky.social · 09/01/2026
#SCMR2026 Best Image Competition ALERT! We invite CMR enthusiasts to submit an image for the SCMR 2026 Best Image Competition. Submit via link below by Jan 30. forms.gle/gp7oqjcGUARRpx… Prize=free admission at SCMR2027! Below are the 2025 and 2024 winners for inspiration #whycmr
071
Reposted by Vass Vassiliou
Trish Greenhalgh @trishgreenhalgh.bsky.social · 26/10/2025
These are great! We all need a Clive. www.theguardian.com/lifeandstyle...
theguardian.com
Start small, keep a log, picture the end result: 17 experts’ top tips on how to stay motivated
Need to psych yourself up for the gym or to blitz your to-do list? Experts including Marie Kondo to Diana Nyad reveal how they keep going when things get tough
3409
Vass Vassiliou @vassv.bsky.social · 26/10/2025
My interview with the JAMA group about iur recent Consensus Document on cardiac Long COVID @jama.com The interview: jamanetwork.com/journals/jam... And the paper: academic.oup.com/eurjpc/advan...
jamanetwork.com
What Is Cardiac Long COVID?
This Medical News article is an interview with the lead author of a new European Society of Cardiology clinical consensus statement on cardiovascular disease prevention and management in COVID-19.
050
Reposted by Vass Vassiliou
TRAstonDrs @castltrastondrs.medsky.network · 24/10/2025
@vassv.bsky.social et al academic.oup.com/eurjpc/advan...
academic.oup.com
Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, t...
Abstract. The coronavirus-associated disease 2019 (COVID-19) pandemic has posed significant challenges due to the complex interplay between SARS-CoV-2 infe
121
Reposted by Vass Vassiliou
TRAstonDrs @castltrastondrs.medsky.network · 24/10/2025
#Medsky🧪 #Idsky #cardiosky #publichealth @jama.com New Guidance on #CardiovascularDisease & #COVID19 From Infection to #LongCOVID to Vaccination jamanetwork.com/journals/jam...
jamanetwork.com
What Is Cardiac Long COVID?
This Medical News article is an interview with the lead author of a new European Society of Cardiology clinical consensus statement on cardiovascular disease prevention and management in COVID-19.
1146
Reposted by Vass Vassiliou
Trish Greenhalgh @trishgreenhalgh.bsky.social · 26/09/2025
New from @sheencr.bsky.social open.substack.com/pub/sheenacr...
open.substack.com
What the current disinformation and discussions on vaccines, Tylenol (Paracetamol), autism could mean for us all.
Disinformation and Disarray in American Health Policy Making
33020
Reposted by Vass Vassiliou
Trish Greenhalgh @trishgreenhalgh.bsky.social · 22/09/2025
New consensus statement on preventing cardiovascular disease in people with COVID-19. #episky #healthpolicy #medsky academic.oup.com/eurjpc/advan...
academic.oup.com
Validate User
23812
Vass Vassiliou @vassv.bsky.social · 21/09/2025
Not often that @erictopol.bsky.social posts about one of our papers! The ESC Consensus statement for Long #COVID We reviewed the evidence & reached a consensus on a diagnostic algorithm, intervention, vaccines, cardiac rehab, sports participation. Worrh a Read academic.oup.com/eurjpc/advan...
academic.oup.com
Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, t...
Abstract. The coronavirus-associated disease 2019 (COVID-19) pandemic has posed significant challenges due to the complex interplay between SARS-CoV-2 infe
01811
Vass Vassiliou @vassv.bsky.social · 18/09/2025
When @erictopol.bsky.social tweets about our paper on #Covid then it is certainly worth a read - Definitely worth a read @drmarthagulati.bsky.social @mmamas1973.bsky.social @purviparwani.bsky.social @anastasiasmihaili.bsky.social
182
Vass Vassiliou @vassv.bsky.social · 19/07/2025
Delighted w our Cunsensus Document on preventing heart failure in cardiac-oncology at #EJHF @escardio.bsky.social onlinelibrary.wiley.com/doi/10.1002/... Potential importance of SGLTi noted academic.oup.com/eurjpc/advan... With great colleagues who R not on Blue Sky-repost to attract them here!
5166
Reposted by Vass Vassiliou
Society for Cardiovascular Magnetic Resonance @scmrorg.bsky.social · 19/06/2025
SCMR is excited to announce that we are currently accepting applications for our 3 funding opportunities the: Seed Grant, Training Fellowship Program, and Outcomes Research Grant. For more information and how to apply, please visit SCMR's Grants page: buff.ly/gFeTGlV @vassv.bsky.social
012
Vass Vassiliou @vassv.bsky.social · 30/05/2025
Protons 🧲 the May NewsBeat is out! Find it here: www.multibriefs.com/briefs/SCMR/... Importantly - u r views COUNT! Tell us what u think of the NewsBeat content 👇 tinyurl.com/877j59a2 … conferences, efucational events, SCMR directory centers, grandfather & more! #whycmr @scmrorg.bsky.social
032
Reposted by Vass Vassiliou
Society for Cardiovascular Magnetic Resonance @scmrorg.bsky.social · 15/05/2025
Last chance! Abstract submissions for the 2025 SCMR Mid-Year Meeting—Recent Advances in Imaging for Congenital Heart Disease CLOSE TOMORROW (May 16). Submit your research for a chance at FREE registration to #SCMR2026 in Rio! Hurry, before it's too late: buff.ly/y6BryKP @vassv.bsky.social
156
Reposted by Vass Vassiliou
Society for Cardiovascular Magnetic Resonance @scmrorg.bsky.social · 09/05/2025
Last chance to SAVE! Early bird prices for the Mid-Year Meeting in Munich END TODAY. Gain insights from world-renowned experts on cutting-edge techniques including AI, 4D flow, parametric mapping and more. Register now before it's too late: buff.ly/RmBOJtK @vassv.bsky.social
001
Reposted by Vass Vassiliou
Society for Cardiovascular Magnetic Resonance @scmrorg.bsky.social · 07/05/2025
Register now to SAVE! Early bird prices for the Mid-Year Meeting in Munich end May 9th. Don't miss insights from world-renowned experts on cutting-edge techniques including AI, 4D flow, parametric mapping and more. Secure your spot before it's too late: buff.ly/RmBOJtK @vassv.bsky.social
113
Reposted by Vass Vassiliou
Society for Cardiovascular Magnetic Resonance @scmrorg.bsky.social · 01/05/2025
Register now to SAVE! We have extended our early bird registration deadline for the Mid-Year Meeting in Munich to May 9th. Gain insights from world-renowned experts on cutting-edge techniques including AI, 4D flow, and parametric mapping. Learn more here: buff.ly/RmBOJtK @vassv.bsky.social
001
Reposted by Vass Vassiliou
heartinmagnet.bsky.social @heartinmagnet.bsky.social · 03/05/2025
🚨#whyCMR reveals heart's TRUE age!🫀Latest work from 4DLAB! @accintouch.bsky.social @bscimaging.bsky.social @sarahmoharem.bsky.social @escardio.bsky.social @vassv.bsky.social @cshenoy.bsky.social @worldheart.org @gimelliale.bsky.social ➡️https://academic.oup.com/ehjopen/article/5/3/oeaf032/8098121
001
Vass Vassiliou @vassv.bsky.social · 25/04/2025
Protons! 🧲 The April @SCMRorg is out 😊 #whycmr Find it here: www.multibriefs.com/briefs/SCMR/... Covering courses, conferences, seminars, a centre from #Mexico from our SCMR directory, research, cases and a lot more! Register for the FREE monthly Newsbeat: tinyurl.com/yarpy99w
053
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 23/04/2025
Our @aspcardio.bsky.social statement on South Asians & Cardiometabolic Health in @ajpcardio.bsky.social I had the honour of co-chairing this w/ the amazing Dr. Rohatji & @jaideeppatel.bsky.social 🙏🏽 to our entire talented team who brought this to life 📎 shorturl.at/4bJGz #CVPrev #Cardiosky
11310
Vass Vassiliou @vassv.bsky.social · 18/04/2025
Definite ‘wrong time, wrong place’ bsky.app/profile/codi...
000
Reposted by Vass Vassiliou
Erin Michos, MD @erinmichos.bsky.social · 18/04/2025
Please to share our state of the art review on "Sex Hormones and Heart Failure Risk" in @jaccjournals.bsky.social #JACCAdv led by Dr. Imo Ebong. Find it here at: www.jacc.org/doi/10.1016/...
0104
Reposted by Vass Vassiliou
Ben Canham @bencanham.bsky.social · 18/04/2025
My name is Ben and I have autism. I’m not less than anyone else I just see the world differently. Lately I’ve been working on losing weight by walking. I walked 5 miles yesterday. It’s also helps with my confidence and I can enjoy the outdoors and the scenery.
3675501443546
Vass Vassiliou @vassv.bsky.social · 16/04/2025
FREE FREE FREE journal club from the European Association of Preventive Cardiology On SGLT2i in Cardio-oncology Do they help? Join to find out! 29th April 1700-1800 CEST Registration: www.escardio.org/The-ESC/ESC-... Article: academic.oup.com/eurjpc/advan... @cardioobdoc.bsky.social
133
Reposted by Vass Vassiliou
Nature Portfolio @natureportfolio.nature.com · 13/04/2025
A study in Nature Medicine exposed LLMs to simulated clinical cases with switched sociodemographic features exploring ethnic, social, sexual orientation and gender dimensions and showed differences in recommendations for patient treatment, referral and follow-up based only on these features. 🔒
go.nature.com
Sociodemographic biases in medical decision making by large language models - Nature Medicine
A panel of nine LLMs was exposed to simulated clinical cases with switched sociodemographic features exploring ethnic, social, sexual orientation and gender dimensions and showed differences in recommendations for patient treatment, referral and follow-up based only on these features.
12010
Vass Vassiliou @vassv.bsky.social · 13/04/2025
000
Reposted by Vass Vassiliou
Altmetric @altmetric.com · 11/04/2025
“On today’s X, #AcademicTwitter is dead. And most scholars in the world do not want to be active on what the platform has become.” ~ @claesdevreese.bsky.social
timeshighereducation.com
X’s dominance ‘over’ as Bluesky becomes new hub for research
Data indicates more scholars turning to alternative social media site to post about their work after Elon Musk’s Twitter takeover
620161
Reposted by Vass Vassiliou
Henry Han @hancardiomd.bsky.social · 08/04/2025
Prognostic value of left atrioventricular coupling index in heart failure In 478 HF patients (LVEF <50%), higher #LACI (≥30.9%) was linked to worse outcomes. academic.oup.com/ehjcimaging/... @escardio.bsky.social @cardioobdoc.bsky.social @vassv.bsky.social @shelleyzieroth.bsky.social
044
Vass Vassiliou @vassv.bsky.social · 12/04/2025
Happy weekend everyone!
000
Vass Vassiliou @vassv.bsky.social · 09/04/2025
Easy and potentially very useful!
011
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 03/04/2025
ESC President opens #ESCPrev2025 discussing AI and the future of #CVprev ✨ remember the AI used to compete in chess? Now it is built into cardiology ✨ Facial recognition can predict CAD! ✨ Speech may give clues to HF ✨ ECG can predict AF and identify prior AF @escardio.bsky.social
034
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 03/04/2025
Will an Avatar be the one to meet with the patient and take the history and make the assessment? How far will AI go? #ESCPrev2025 #EAPC #AI #thefutureofCVPrev #CVPrev
033
Vass Vassiliou @vassv.bsky.social · 03/04/2025
An amazing case presented @drmarthagulati.bsky.social on cardiovascular risk that can be identified during pregnancy #ESCPrev2025 Pregnancy and opportunity to identify those at risk later in life eg pregnancy diabetes, hypertension, pre-eclampsia An opportunity to Prevent future events!
000
Reposted by Vass Vassiliou
Giuseppe Biondi-Zoccai @gbiondizoccai.bsky.social · 27/03/2025
Are you ready to join us for this year's #ESCPrev2025 in Milan, Italy, to refine your skills and broaden your knowledge in #cvprev? www.escardio.org/Congresses-E...
113
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 03/04/2025
And now we have opened and started the sessions on #CVprev 👏🏽👏🏽👏🏽👏🏽👏🏽 #ESCPrev2025 #EAPC The future of prevention is now!
093
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 03/04/2025
#EAPC -#ESCPrev2025 Dr. Pinto @anastasiasmihaili.bsky.social Dr. Neubeck and myself Together in Milano!
092
Reposted by Vass Vassiliou
Matheus Hausen @matheushausen.bsky.social · 03/04/2025
Inaugural session at #ESCPrev2025, Milan! ❤️💚
031
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 02/04/2025
Bella Milano! #ESCPrev2025 starts tomorrow! Perfect weather in a perfect city! Cannot wait to see everyone #CVPrev #CardioSky
2112
Reposted by Vass Vassiliou
Dr Martha Gulati @drmarthagulati.bsky.social · 02/04/2025
Last leg of my travels to #ESCPrev2025 in Milan Cannot wait to see everyone soon! @vassv.bsky.social @escardio.bsky.social #CVprev #CardioSky Follow me for updates from the conference
0154
Vass Vassiliou @vassv.bsky.social · 30/03/2025
Amazing results for DAPA in post TAVI pts @nejm.org www.nejm.org/doi/full/10.... 28% reduction in MACE Some caveats pts w diabetes and reduced LVEF who were eligible anyway randomised, but great study! Now time to look at moderate AS- don’t worry, we are doing it!!! @drmarthagulati.bsky.social
011
Vass Vassiliou @vassv.bsky.social · 28/03/2025
Two years ago we published our seminal meta-analysis on risk factors of long covid- cited 548 times & the WHO guidelines @JAMA.com jamanetwork.com/journals/jam... Females, elderly, smokers, obese, comorbidities & hospitalisation had higher risk One thing protected from long covid: vaccination
254
Reposted by Vass Vassiliou
Henry Han @hancardiomd.bsky.social · 22/03/2025
Impact of #SGLT2i on heart failure outcomes in #cancer patients and survivors: SR-MA 📌SGLT2i use in cancer patients ⬇️ HF 🏥 by 51% and new HF Dx by 71% academic.oup.com/eurjpc/advan... #CardioSky @escardio.bsky.social @vassv.bsky.social @cardioobdoc.bsky.social
156
Vass Vassiliou @vassv.bsky.social · 21/03/2025
FREE FREE FREE EAPC Journal Club 26 March 2025 - 17:00 - 18:00 CET Risk profile & prognostic implications of premature advanced coronary atherosclerotic disease among young to early middle-aged adults: the coronary artery calcium consortium Register here: www.escardio.org/The-ESC/ESC-...
033
Vass Vassiliou @vassv.bsky.social · 07/03/2025
Am doing an informal poll- will bluesky or X give most reposts for our last paper? @benoyshah.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @jgrapsa.bsky.social @anastasiasmihaili.bsky.social @annakatebarton.bsky.social @tharusha.bsky.social academic.oup.com/eurjpc/advan...
academic.oup.com
Impact of sodium–glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis
AbstractAims. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are recognized for their cardiovascular benefits. This systematic review and meta-analysis
386
Reposted by Vass Vassiliou
Giuseppe Biondi-Zoccai @gbiondizoccai.bsky.social · 07/03/2025
Out of my >1,100 publications, this is one I am very proud of: Cardiovascular scholarly challenges following the Russian invasion of Ukraine, by Pirlamarla, Sabouret, Kozhukhov, Marchenko, Hill, and Mamas (free full text here: www.minervamedica.it/en/journals/...) #MinervaCardiologyAngiology
011
Vass Vassiliou @vassv.bsky.social · 06/03/2025
Our latest paper on EJPC @escardio.bsky.social on use of SGLT2i in cancer patients… Reduces heart failure hospitalisation by 50%! And mortality! Breaat ca pts benefit most Read it at: academic.oup.com/eurjpc/advan... @drmarthagulati.bsky.social @purviparwani.bsky.social @mmamas1973.bsky.social
175
Reposted by Vass Vassiliou
Giuseppe Biondi-Zoccai @gbiondizoccai.bsky.social · 14/02/2025
In patients with HF & EF>40%, APTURE shunt confirmed an acceptable safety profile with improvements in HF symptoms, quality-of-life, and functional capacity without negatively affecting right and left heart function after 2 years, regardless of pulmonary vascular disease www.jacc.org/doi/10.1016/...
022
Vass Vassiliou @vassv.bsky.social · 12/02/2025
Is there a role of polygenic risk scores in predicting cardiac disease? Some say ‘yes’ some say ‘no’! Read our recent consensus statement from the ESC @escardio in #EHJ and then can make up your mind! bit.ly/3WQowaa @drmarthagulati.bsky.social @mmamas1973.bsky.social @purviparwani.bsky.social
031
Vass Vassiliou @vassv.bsky.social · 31/01/2025
So true!
000
Reposted by Vass Vassiliou
Anna Giulia Pavon @annagiuliapavon.bsky.social · 30/01/2025
#SCMR2025 Happy to start the 2nd day on #whyCMR discussion cardiac masses! 🏠Kiosk 1 - blue room ⏰8-9 AM 👉Many tips and tricks for patients diagnosis and management 👉Learn from cases is essential! 🧲See u there!
111